google_counter
Treatment of Non-Hodgkin lymphoma (B-cell) with CAR T-cell therapy (690772) | St. Antonius Hospital Eschweiler - BookingHealth
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Physical examination<\/li>\n\t<li>Review of medical records<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>Complete blood count<\/li>\n\t\t<li>General urine analysis<\/li>\n\t\t<li>Biochemical blood test (kidney and liver function tests)<\/li>\n\t\t<li>Indicators of inflammation (CRP, ESR)<\/li>\n\t\t<li>Indicators of blood coagulation<\/li>\n\t\t<li>Immunohistochemical and genetic analysis of tumor cells (if indicated)<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Leukapheresis, processing of T-cells and cultivation of CAR T-cells<\/li>\n\t<li>Adjuvant chemotherapy<\/li>\n\t<li>Infusion of modified CAR T-cells to a patient<\/li>\n\t<li>Control examinations<\/li>\n\t<li>Cost of essential medicines and materials<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Full hospital accommodation<\/li>\n\t<li>Explanation of future recommendations<\/li>\n<\/ul>\n<div class=\"program_indications_for_surgery\"><h4>Indications<\/h4><ul>\n\t<li>Non-Hodgkin lymphoma (B-cell) that is resistant to the conventional therapy<\/li>\n<\/ul>\n<\/div><div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p><strong>Days 1-2<\/strong>. Initial presentation at the clinic. The doctor collects the patient&#39;s medical history, looks at his medical records and previous examinations. Special attention is paid to previous cancer treatments and their results, since CAR T-cell therapy is indicated only if the conventional treatment protocols are ineffective. Based on the results of the consultation, the doctor administers the examination, which includes a complete blood count with white blood cell count, assessment of liver and kidney function, immunohistochemical and genetic analysis of tumor cells (if indicated) and other studies.<\/p>\n\n<p><strong>Day 3<\/strong>. Collecting patient&rsquo;s blood. During the leukapheresis procedure, doctors harvest at least 100 million T-cells, which will subsequently undergo gene modification. If there are certain clinical reasons, and the patient needs to postpone the subsequent stages of CAR T-cell therapy, the harvested T-cells undergo the procedure of cryoconservation. If the patient is able to continue treatment immediately, then the harvested T-cells are transferred to the laboratory.<\/p>\n\n<p><strong>Days 4-12<\/strong>. Processing and gene modification of the T-cells pool lasts 7-10 days. During this time, the patient is receiving immunosuppressive chemotherapy drugs. The chemotherapy is aimed at suppressing the patient&#39;s own immune system, which will allow CAR T-cells to fight the tumor more effectively.<\/p>\n\n<p><strong>Day 13<\/strong>. Manufactured CAR T-cells are tested for the microbiological safety and functional activity. After the successful testing completion, the solution with CAR T-cells is administered to the patient intravenously.<\/p>\n\n<p><strong>Day 14 and other days<\/strong>. Control examination and further medical supervision in the hospital are carried out. If there are no side effects of CAR T-cell therapy, a stable tendency towards normalization of blood count is observed and the patient has stable general health condition, the patient is discharged from the hospital. Before the discharge, the patient receives the detailed recommendations for further follow-up during the disease remission.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li>Complete blood count with white blood cell count<\/li>\n\t<li>Biochemical blood test (renal and liver function tests), if available<\/li>\n\t<li>Bone marrow biopsy results<\/li>\n\t<li>CT scan, if available<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Physical examination<\/li>\n\t<li>Review of medical records<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>Complete blood count<\/li>\n\t\t<li>General urine analysis<\/li>\n\t\t<li>Biochemical blood test (kidney and liver function tests)<\/li>\n\t\t<li>Indicators of inflammation (CRP, ESR)<\/li>\n\t\t<li>Indicators of blood coagulation<\/li>\n\t\t<li>Immunohistochemical and genetic analysis of tumor cells (if indicated)<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Leukapheresis, processing of T-cells and cultivation of CAR T-cells<\/li>\n\t<li>Adjuvant chemotherapy<\/li>\n\t<li>Infusion of modified CAR T-cells to a patient<\/li>\n\t<li>Control examinations<\/li>\n\t<li>Cost of essential medicines and materials<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Full hospital accommodation<\/li>\n\t<li>Explanation of future recommendations<\/li>\n<\/ul>\n<div class=\"program_indications_for_surgery\"><h4>Indications<\/h4><ul>\n\t<li>Non-Hodgkin lymphoma (B-cell) that is resistant to the conventional therapy<\/li>\n<\/ul>\n<\/div><div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p><strong>Days 1-2<\/strong>. Initial presentation at the clinic. The doctor collects the patient&#39;s medical history, looks at his medical records and previous examinations. Special attention is paid to previous cancer treatments and their results, since CAR T-cell therapy is indicated only if the conventional treatment protocols are ineffective. Based on the results of the consultation, the doctor administers the examination, which includes a complete blood count with white blood cell count, assessment of liver and kidney function, immunohistochemical and genetic analysis of tumor cells (if indicated) and other studies.<\/p>\n\n<p><strong>Day 3<\/strong>. Collecting patient&rsquo;s blood. During the leukapheresis procedure, doctors harvest at least 100 million T-cells, which will subsequently undergo gene modification. If there are certain clinical reasons, and the patient needs to postpone the subsequent stages of CAR T-cell therapy, the harvested T-cells undergo the procedure of cryoconservation. If the patient is able to continue treatment immediately, then the harvested T-cells are transferred to the laboratory.<\/p>\n\n<p><strong>Days 4-12<\/strong>. Processing and gene modification of the T-cells pool lasts 7-10 days. During this time, the patient is receiving immunosuppressive chemotherapy drugs. The chemotherapy is aimed at suppressing the patient&#39;s own immune system, which will allow CAR T-cells to fight the tumor more effectively.<\/p>\n\n<p><strong>Day 13<\/strong>. Manufactured CAR T-cells are tested for the microbiological safety and functional activity. After the successful testing completion, the solution with CAR T-cells is administered to the patient intravenously.<\/p>\n\n<p><strong>Day 14 and other days<\/strong>. Control examination and further medical supervision in the hospital are carried out. If there are no side effects of CAR T-cell therapy, a stable tendency towards normalization of blood count is observed and the patient has stable general health condition, the patient is discharged from the hospital. Before the discharge, the patient receives the detailed recommendations for further follow-up during the disease remission.<\/p>\n<\/div>","is_ambulant":"0","bh_fee":"0","only_for_children":"0","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"0","clinic_icon":"60055f2f152da.jpg","city":"Eschweiler","clinic_site":"www.sah-eschweiler.de","department_recommend":"0","country":"Germany","country_id":"1","clinic_name":"St. Antonius Hospital Eschweiler","cinic_name":"St. Antonius Hospital Eschweiler","department_id":"137","duration":"21","direction":"Hematology","min_duration":0,"clinic_id":"41","paketPrice":36000,"paket":"<ul>\n <li>Interpreter up to 80 hours<\/li>\n <li>Translation up to 15 pages<\/li>\n <li>Visa support<\/li>\n<\/ul>","title":"Treatment of Non-Hodgkin lymphoma (B-cell) with CAR T-cell therapy","price":{"val":454195.08,"type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"need_to_use_head_doctor","title":"Treatment by leading experts","type":"val","val":"60480.00","req":0},{"id":"1_person_room","title":" Single room (whole period)","parent":"duration","type":"count_val","val":"168.00"},{"id":"2_person_room","title":" double room (whole period)","parent":"duration","type":"count_val","val":"86.00"},{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"7","distance":"73","airport_title":"Cologne-Bonn"},{"id":"4","distance":"92","airport_title":"Duesseldorf"},{"id":"6","distance":"236","airport_title":"Frankfurt a.M."}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Treatment of Non-Hodgkin lymphoma (B-cell) with CAR T-cell therapy in St. Antonius Hospital Eschweiler

St. Antonius Hospital Eschweiler

Eschweiler, Germany
Program id # 690772
Doctor photo
PD Dr. med. Peter Staib
Department of Hematology and Oncology
Specialized in: hematology, oncology

The program includes:

  • Initial presentation in the clinic
  • Clinical history taking
  • Physical examination
  • Review of medical records
  • Laboratory tests:
    • Complete blood count
    • General urine analysis
    • Biochemical blood test (kidney and liver function tests)
    • Indicators of inflammation (CRP, ESR)
    • Indicators of blood coagulation
    • Immunohistochemical and genetic analysis of tumor cells (if indicated)
  • Leukapheresis, processing of T-cells and cultivation of CAR T-cells
  • Adjuvant chemotherapy
  • Infusion of modified CAR T-cells to a patient
  • Control examinations
  • Cost of essential medicines and materials
  • Nursing services
  • Full hospital accommodation
  • Explanation of future recommendations

Indications

  • Non-Hodgkin lymphoma (B-cell) that is resistant to the conventional therapy

How program is carried out

Days 1-2. Initial presentation at the clinic. The doctor collects the patient's medical history, looks at his medical records and previous examinations. Special attention is paid to previous cancer treatments and their results, since CAR T-cell therapy is indicated only if the conventional treatment protocols are ineffective. Based on the results of the consultation, the doctor administers the examination, which includes a complete blood count with white blood cell count, assessment of liver and kidney function, immunohistochemical and genetic analysis of tumor cells (if indicated) and other studies.

Day 3. Collecting patient’s blood. During the leukapheresis procedure, doctors harvest at least 100 million T-cells, which will subsequently undergo gene modification. If there are certain clinical reasons, and the patient needs to postpone the subsequent stages of CAR T-cell therapy, the harvested T-cells undergo the procedure of cryoconservation. If the patient is able to continue treatment immediately, then the harvested T-cells are transferred to the laboratory.

Days 4-12. Processing and gene modification of the T-cells pool lasts 7-10 days. During this time, the patient is receiving immunosuppressive chemotherapy drugs. The chemotherapy is aimed at suppressing the patient's own immune system, which will allow CAR T-cells to fight the tumor more effectively.

Day 13. Manufactured CAR T-cells are tested for the microbiological safety and functional activity. After the successful testing completion, the solution with CAR T-cells is administered to the patient intravenously.

Day 14 and other days. Control examination and further medical supervision in the hospital are carried out. If there are no side effects of CAR T-cell therapy, a stable tendency towards normalization of blood count is observed and the patient has stable general health condition, the patient is discharged from the hospital. Before the discharge, the patient receives the detailed recommendations for further follow-up during the disease remission.

Required documents

  • Complete blood count with white blood cell count
  • Biochemical blood test (renal and liver function tests), if available
  • Bone marrow biopsy results
  • CT scan, if available

Service

Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Hospital directly:
Saving:
Guarantee BookingHealth Price from:

About the department

The Department of Hematology and Oncology at the St. Antonius Hospital Eschweiler provides the full range of medical services in the areas of its competence. The department specializes in the diagnostics and treatment of benign and malignant diseases of the hematopoietic system, as well as solid tumors of various localization. The department's doctors focus on the patients with acute and chronic leukemia, malignant lymphomas, malignant tumors of the gastrointestinal tract, lungs, breast, female reproductive organs, prostate gland, soft tissues and bones. The patients with advanced cancer are offered high quality palliative care to relieve pain and improve their quality of life. The Chief Physician of the department is PD Dr. med. Peter Staib.

The department regularly holds interdisciplinary tumor boards with the participation of oncologists and doctors from related medical specialties. These tumor boards serve for considering each clinical case individually and careful planning of the subsequent treatment. When developing a treatment regimen, the doctors take into account all the slightest clinical aspects, which guarantees a successful treatment outcome. In addition, the department's doctors take part in many national and international research projects. Therefore, in addition to classical treatment methods, they can offer the very latest drugs and therapeutic methods, which have proven their high efficiency during clinical trials.

The department has excellent technical equipment for making an accurate diagnosis, determining the stage of the oncological process, localizing the tumor, the presence or absence of metastases and obtaining other important clinical data, on the basis of which the specialists develop an individual treatment regimen for each patient. The therapeutic procedures are appointed in strict accordance with current clinical protocols. When planning treatment, the recommendations of the German Society of Hematology and Oncology, as well as the German Cancer Society are also taken into account. The department's doctors are always open to personal communication with the patients and their relatives, as well as support patients on their way to recovery in every possible way. Whenever required, experienced psychologists can also be involved in the therapeutic process.

The department's medical team has at its command a variety of advanced treatments, which help effectively fight cancer and achieve good treatment outcomes even in particularly complex clinical cases, which are considered hopeless by the specialists in other medical facilities. The department's doctors successfully use innovative chemotherapy regimens, drug therapy with modern anticancer drugs, including immunotherapy, antibody therapy, antihormone therapy, radiation therapy, etc. The surgical treatment is provided in collaboration with highly qualified surgeons. The department's competence does not include bone marrow transplantation, but the doctors prepare the patients for this procedure and offer high-quality specialized patient care after it. 

The department offers both diagnostics and treatment of the following diseases:

  • Hematology
    • Malignant diseases
      • Acute and chronic leukemia
      • Hodgkin's lymphoma
      • Non-Hodgkin's lymphoma
      • Myelodysplastic syndrome
      • Myeloma
    • Benign diseases
      • Bleeding disorders
      • Anemia
      • Thalassemia
      • Thrombocytopenia
      • Polycythemia
      • Hemophilia
  • Oncology
    • Malignant gastrointestinal tumors (gastric, colon, esophageal, pancreatic cancers, etc.)
    • Malignant tumors of the lungs and other thoracic organs
    • Malignant tumors of the female reproductive organs (cervical, ovarian, vulvar cancers, etc.)
    • Malignant head and neck tumors
    • Malignant soft tissue and bone tumors
    • Breast cancer
    • Prostate cancer
  • Other diseases

The department's range of therapeutic services includes:

  • Chemotherapy (both on an inpatient and outpatient basis)
  • Drug therapy with modern anticancer drugs, including immunotherapy
  • Antibody therapy
  • Anti-hormonal therapy
  • Radiation therapy
  • Treatment with innovative drugs, which have proven their effectiveness during the clinical trials, including treatment within clinical trials (at the patient's request)
  • Preparation for bone marrow transplantation and follow-up care
  • Palliative care
  • Pain therapy
  • Diet therapy
  • Psychological care
  • Other medical services

Photo of the doctor: (c) St.-Antonius-Hospital


About hospital

According to the prestigious Focus magazine, the St. Antonius Hospital Eschweiler ranks among the top medical facilities in North Rhine-Westphalia!

The hospital is a modern medical complex with 13 specialized departments. The hospital has more than 165 years of history, so it has long won an excellent reputation not only in Germany, but also in the European medical arena. In addition, the medical facility has the status of the Academic Hospital of the RWTH Aachen University, thanks to which it can offer patients the very latest and unique medical advances. The highly qualified medical staff of the hospital, consisting of more than 1,300 employees, is focused on high-quality medical services with due consideration of the personal needs and wishes of patients

The medical complex has 443 beds. More than 15,000 inpatients undergo diagnostics and treatment on an inpatient basis, while about 25,000 patients receive ambulatory medical care. The specialists of the hospital often provide diagnostic services and treatment to the patients from foreign countries.

The main areas of clinical practice of the medical facility include oncology, hematology, general and abdominal surgery, plastic surgery, hand surgery, vascular surgery, internal medicine, gynecology, urology and radiation oncology. Each area is represented by an experienced team of doctors and specially trained nursing staff, whose task is to provide the accurate diagnostics and the most effective treatment. The work of the medical staff is based on the use of modern technical resources, as well as classic and innovative treatment methods. The doctors from different medical specialties cooperate closely with each other, so the slightest details and characteristics of the patient's body are taken into account when planning and providing treatment. In addition, the medical staff is always open to personal communication with the patients, strives for their moral support on their way to recovery and surrounds them with care.

The outstanding achievements of the hospital and high treatment success rates are confirmed by the quality certificates of the German Cancer Society, the German Cardiac Society, the German Society of Vascular Surgery, the German Society of Hematology and Medical Oncology and the German Trauma Society. In addition, according to the famous Focus magazine, the hospital is recognized as one of the best medical centers in Germany specializing in the treatment of breast cancer, prostate cancer and cardiovascular diseases.

Photo: (с) depositphotos

Accommodation in hospital

Patients rooms

The patients of the St. Antonius Hospital Eschweiler live in cozy and light rooms. All the patient rooms are well equipped to make the patient feel as comfortable as possible throughout the entire period of hospital stay. The patient room includes an automatically adjustable bed, a bedside table, a wardrobe, a TV and a telephone. Each patient room has an ensuite bathroom with shower and toilet. Some patient rooms have specially designed bathrooms for disabled people. The patient rooms also have Wi-Fi.

If desired, the patient with his accompanying person can live in the enhanced comfort room. These patient rooms are additionally equipped with upholstered furniture, a mini fridge and a safe for storing valuables.

Meals and Menus

The patient and his accompanying person are offered tasty and healthy three meals a day: breakfast, lunch and dinner. Breakfast and dinner are served buffet style, while for lunch there is a choice of three set menus. If for some reason you do not eat all the foods, you will be offered an individual menu.

The hospital also has a cozy cafe with a large choice of salads, main courses, pizza, cakes and ice cream. Here you can enjoy aromatic coffee, delicious tea or soft drinks.

Further details

Standard rooms include:

Toilet
Shower
Wi-Fi
TV

Religion

The religious services are available upon request.

Accompanying person

During the inpatient program, the accompanying person can live with the patient in a patient room or a hotel of his choice. Our managers will help you choose the most suitable option.

Hotel

During the outpatient program, the patient can stay at the hotel of his choice. Our managers will help you choose the most suitable option.